The Truth & Debunking Myths About Life Science Exits


Cozen O'Connor 

1650 Market Street 

Suite 2800 

Philadelphia, PA 

Date & Time

Start Date: 10/24/2019
Start Time: 6:00 p.m.
End Date: 10/24/2019
End Time: 8:00 p.m.


Life science investing is different from other technology investing. There are hurdles faced in testing and clinical trials that do not have a comparison in the technology silo. Life science companies may need to go through several series of venture or collaboration funding and can travel very different journeys to get to an exit. In addition, within life science, the strategy of the startup company can differ based on how it chooses to navigate the path of product development and commercial marketing. Join Cozen O’Connor and the Philadelphia-Israel Chamber of Commerce for a dynamic discussion on investing followed by a reception to connect with colleagues from the industry.



David Baker, Co-Founder, Vallon Pharmaceuticals